[KTTA] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
12-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -6,951.13%
YoY- -671,160.98%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 976 0 0 0 241 219 14 1580.82%
PBT -5,031 -3,613 -3,598 -3,266 -5,118 -4,191 -2,658 52.83%
Tax 17 -162 -65 271,869 -1,215 730 -843 -
NP -5,048 -3,613 -3,763 -275,135 -3,902 -4,586 -1,815 97.40%
Tax Rate - - - - - - - -
Total Cost 6,024 3,613 3,763 275,135 4,143 4,805 1,829 120.88%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -517.07 0.00 0.00 0.00 -1,621.19 -2,097.88 -13,364.21 -88.49%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -4.85 -2.87 -2.88 -211.05 -3.00 -3.45 -0.08 1431.74%
EPS Diluted -4.85 -2.87 -2.88 -211.05 -3.00 -3.45 -0.08 1431.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.